Pharmed Expert Spółka z Ograniczoną Odpowiedzialnością (KRS 0000637795, NIP 7511775987) is a Polish company, headquartered in Kluczbork, Opolskie voivodeship. PHARMED EXPERT operates in: Computer programming activities (PKD 62.01.Z). Industry: IT and software. The company has been listed in the National Court Register since September 19, 2016. PHARMED EXPERT's most recently reported net revenue was 0 PLN for 2023. PHARMED EXPERT's operations are currently suspended.
The company is currently suspended
Suspended since July 1, 2024
Negative equity
Negative equity in 6 of 6 available reporting years.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Business profile - Pharmed Expert
Identity
- Name
- Pharmed Expert Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
- Founded
- September 19, 2016
- Registry status as of
- November 21, 2025
- Latest entry
- July 15, 2024
- Founding act
- 14.09.2016R.
Articles of association history (2)
- September 14, 2016: 14.09.2016R.
- June 30, 2020: 30.06.2020R., ZMIENIONO §4 UMOWY SPÓŁKI
Activities
Main activity
62.01.ZComputer programming activities
General codes (divisions and groups)
General codes indicate a PKD division or group without a specific subclass.
Address and contact
- Address
- UL. SIENKIEWICZA, 22, 46-200, KLUCZBORK, POLSKA
- Voivodeship
- OPOLSKIE
- District
- KLUCZBORSKI
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- Not disclosed in the registry
Risk and payment profile - Pharmed Expert
Credibility rating
5 / 100
Very poor credibility
Insolvency risk
suspended
Significant formal threat
Closure risk
80
/ 100
Extremely high risk
Risk comparison - scale 0 (safe) → 100 (critical)
Organizational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
0
0/10 yrs
Board changes
1
1/10 yrs
PKD changes
1
1/10 yrs
Name changes
0
0/10 yrs
Data from 10 years of registry activity.
Credibility history
Payment reliability score from 2018–2023
Current: S (5/100)
Trend: stable (0.0 pts/year)
Spółka jest obecnie zawieszona – działalność operacyjna wstrzymana, wskaźnik wiarygodności odzwierciedla stan przed zawieszeniem.
Trade credit limit history
Standard limit from 2018–2023
Current: 0 PLN
Safe: 0 PLN
Operational status - Pharmed Expert
Founded
September 19, 2016
9 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
KLUCZBORK
OPOLSKIE
Primary PKD
62.01.Z
Computer programming activities
Share capital
5.0 K PLN
90 shares total
Shareholders
1
shareholder
Board
1 person
Filed years
6 years
2018–2023 · profitable: 1/6
Registry entries
28
latest: July 15, 2024
Risk signals
Revenue
0 PLN
2023
Net profit
-14.0 K PLN
2023
Assets
55.6 K PLN
2023
Equity
-346.5 K PLN
2023
EBITDA
-7.1 K PLN
2023
Valuation
0 PLN
suspended
Companies in the same location
EU Funds
Projects co-financed by the European Union for Pharmed Expert - total value, EU contribution and the company's largest awards.
Projects
1
EU co-financing
346.3 K PLN
Total project value
1.2 M PLN
Eligible spending
582.0 K PLN
Funds
Operational programmes
- Regionalny Program Operacyjny Województwa Opolskiego 2014-2020
Largest projects
Top 1 by EU co-financing
| Project | Fund | EU co-financing | Value | Rate | Period |
|---|---|---|---|---|---|
Wdrożenie przez przedsiębiorstwo Pharmed Expert Sp. z o.o. w Kluczborku usługi elektronicznej w modelu SaaS wspomagającej podmioty zarządzające aptekami i placówkami medycznymi w rekrutowaniu farmaceutów i pielęgniarek o wymaganych kompetencja |
Public procurement
Trademarks
Reviews
Rate business credibility - Pharmed Expert.
No ratings
Related articles
News
Ailleron in 2026: record PLN 579.7 m revenue, the Tailwind deal for Software Mind collapses, LiveBank moves into Canada
Kraków-based Ailleron S.A. (KRS 0000385276) closed 2025 with record revenue of PLN 579.7 m (+4% YoY) and net profit of PLN 25.7 m, with 77% of sales generated from exports. In April 2026 negotiations with Tailwind Capital Partners over a 100% sale of Software Mind broke down. New CEO Tomasz Król is betting on LiveBank expansion in North and South America (contract with one of Canada's top-5 banks).
News
Asseco Business Solutions: board recommends a PLN 3.75 per share dividend (+14% YoY) after a record 2025
Asseco Business Solutions S.A. (KRS 0000028257, Lublin) closed 2025 with record revenue of PLN 476.77 m (+11.2% YoY), EBITDA of PLN 185.3 m (+12.8%) and net profit of PLN 132.9 m (+15.5%). The board recommends a PLN 3.75 per share dividend, 14% higher than in 2024 (PLN 3.30). The total payout is PLN 125.32 m; the final decision rests with the AGM. ABS remains a subsidiary of Asseco Poland.
